| 2024-04 |
Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis |
International Journal of Cardiology
|
| 2024-01 |
Random intercept hierarchical linear models for multi-regional clinical trials |
Journal of Biopharmaceutical Statistics
|
| 2022-07 |
Hierarchical Generalized Linear Models for Multiregional Clinical Trials |
STATISTICS IN BIOPHARMACEUTICAL RESEARCH
|
| 2022-05 |
ACGCN: Graph Convolutional Networks for Activity Cliff Prediction between Matched Molecular Pairs |
Journal of Chemical Information and Modeling
|
| 2022-01 |
The determination of biosimilarity margin and the assessment of biosimilarity for an -arm parallel design |
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS
|
| 2022-01 |
Effects of between-batch variability on the type I error rate in biosimilar development |
COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION
|
| 2020-00 |
Statistical assessment of biosimilarity based on the relative distance between follow-on biologics for time-to-event endpoints |
STATISTICS IN BIOPHARMACEUTICAL RESEARCH
|
| 2020-00 |
Hierarchical Linear Models for Multi-regional Clinical Trials |
STATISTICS IN BIOPHARMACEUTICAL RESEARCH
|
| 2018-07 |
Statistical Implications of Extrapolating the Overall Result to the Target Region in Multi-Regional Clinical Trials |
Communications for Statistical Applications and Methods
|
| 2017-03 |
Sample Size Calculations for Combination Drugs of Two Monotherapies with One Approved Dose Level: Binary Endpoint Cases |
THERAPEUTIC INNOVATION & REGULATORY SCIENCE
|
| 2016-05 |
Avoiding ambiguity with the Type I error rate in noninferiority trials |
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
|
| 2016-03 |
Statistical Assessment of Biosimilarity based on the Relative Distance between Follow-on Biologics for Binary Endpoints |
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
|
| 2015-09 |
Statistical Assessment of Biosimilarity based on the Relative Distance between Follow-on Biologics in the (k+1)-arm Parallel Design |
Communications for Statistical Applications and Methods
|
| 2015-07 |
Sample Size Calculations for the Development of Biosimilar Products Based on Binary Endpoints |
Communications for Statistical Applications and Methods
|
| 2015-03 |
Book Review <Randomized Response- Adaptive Designs in Clinical Trials> |
BIOMETRICS
|
| 2014-11 |
Sample Size Calculations for the Development of Biosimilar Products |
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
|
| 2014-10 |
Sample Size Calculations for Combination Drugs of Two Monotherapies With One Approved Dose Level |
STATISTICS IN BIOPHARMACEUTICAL RESEARCH
|
| 2013-12 |
Developing of exact tests for order-restrictions in categorical data |
응용통계연구
|
| 2013-10 |
항고혈압 약물 3종 복합제에 대한 선진 외국의 임상자료 심사사례 비교 |
한국임상약학회지
|
| 2013-03 |
Strength of evidence of noninferiority trials with the two confidence interval method with random margin |
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
|
| 2013-02 |
Statistical assessment of biosimilarity based on relative distance between follow-on biologics |
STATISTICS IN MEDICINE
|
| 2013-01 |
Sample Size of Thorough QTc Clinical Trial Adjusted for Multiple Comparisons |
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
|
| 2012-08 |
Statistical Methods in Non-Inferiority Trials - A Focus on US FDA Guidelines - |
응용통계연구
|
| 2012-02 |
바이오시밀러 개발에 필요한 통계방법들에 대한 고찰 |
응용통계연구
|
| 2011-08 |
백신임상시험에 대한 통계적 고찰 |
응용통계연구
|
| 2011-03 |
The Adjustment of the Type I Error Rate in Noninferiority Trials with -Margin Approach: Each of Two Different New Drugs is Approved with Two Independent Trials with the Same Active Control |
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
|
| 2010-10 |
The Comparison of the Unconditional and Conditional Exact Power of Fisher's Exact Test |
응용통계연구
|
| 2010-10 |
New Confidence Intervals for the Proportion of Interest in One-Sample Correlated Binary Data |
Communications In Statistics-Theory And Methods
|
| 2010-08 |
The Eccentric Properties of the Chi-Squared Test with Yates' Continuity Correction in Extremely Unbalanced 2 * 2 Contingency Tables |
응용통계연구
|
| 2010-06 |
Strength of evidence of non-inferiority trials-The adjustment of the type I error rate in non-inferiority trials with the synthesis method |
Statistics In Medicine
|
| 2009-09 |
Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group |
Drug Information Journal
|
| 2009-04 |
현재 국내임상시험에서 독립적 자료모니터링위원회의 필요성 |
응용통계연구
|
| 2008-12 |
An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint |
Drug Information Journal
|
| 2008-10 |
동등성 시험을 신뢰구간을 사용하여 검정하는 경우 왜 신뢰도 90\%인 신뢰구간을 사용하는가? |
응용통계연구
|